STOCK TITAN

Healthlynked - HLYK STOCK NEWS

Welcome to our dedicated page for Healthlynked news (Ticker: HLYK), a resource for investors and traders seeking the latest updates and insights on Healthlynked stock.

HealthLynked Corp (OTCQB: HLYK) is revolutionizing the healthcare industry through its innovative technology platform that integrates patients with healthcare providers. By enabling a more comprehensive and connected healthcare experience, HealthLynked offers solutions such as real-time scheduling, electronic medical records, online telemedicine, emergency contact information, and medication lists and interactions. These features aim to reduce wait times and improve the accuracy and portability of medical information.

Recent achievements include the introduction of advanced search functionalities on its website and mobile applications, making it easier for patients to find and book appointments with healthcare providers even after business hours. This enhancement underscores HealthLynked's commitment to leveraging technology to improve healthcare accessibility and connectivity.

HealthLynked’s cloud-based network empowers members to actively manage their healthcare by providing a centralized, secure location for their medical data, including medications, allergies, past surgeries, and personal health records. Healthcare providers benefit from improved patient care and key insights into their practice operations. Providers who join the HealthLynked network can also utilize marketing tools to engage with patients, ensuring better compliance and optimized scheduling.

Under the leadership of CEO Dr. Michael Dent and CTO Chris Hall, HealthLynked continues to be at the forefront of healthcare innovation, striving to meet the evolving needs of both patients and providers. The company actively encourages patients to take a more active role in their healthcare by connecting them with family members and doctors through new strategies and initiatives.

For more information, visit HealthLynked Corp and stay updated through their social media channels on Facebook, Twitter, Instagram, and LinkedIn.

Rhea-AI Summary

HealthLynked Corp. (OTCQB: HLYK) has released its Annual Shareholder Letter detailing key achievements in 2024 and strategic priorities for the future. The company launched several significant initiatives including: ARI, an AI-powered healthcare guidance system for personalized medical recommendations; nationwide expansion of 24/7 telemedicine services beyond Florida; introduction of a premium concierge service with monthly subscription; and implementation of a discount prescription drug program.

The company's growth strategy focuses on scaling its platform through innovative marketing campaigns and strategic partnerships. HealthLynked plans to enhance affinity marketing by collaborating with insurance providers, major employers, and professional employer organizations (PEOs) to expand its membership base. The company's vision centers on transforming healthcare through improved care management, increased healthcare access, and leveraging patient data for medical research advancement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
none
-
Rhea-AI Summary

HealthLynked has announced the release of ARi, an AI-driven personal healthcare assistant that aims to revolutionize patient engagement and personalized care. The patent-pending technology offers exclusive access to paid members through the HealthLynked app. Key features include personalized healthcare recommendations, effortless scheduling with voice commands, proactive health tracking, and 24/7 intelligent assistance. ARi's platform integrates seamlessly with HealthLynked's ecosystem, allowing users to manage their healthcare efficiently.

CEO Dr. Michael Dent highlighted ARi's role in providing personalized medical care, emphasizing its capabilities like voice-driven profile creation, tailored recommendations, and AI-powered diagnostic support. The technology aims to enhance diagnostic accuracy and connect patients to appropriate care, fostering a more engaged and proactive approach to healthcare.

The release is seen as a significant milestone in HealthLynked's mission to deliver smarter, patient-centered healthcare by leveraging advanced AI to empower patients with better control over their health.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
36.4%
Tags
AI
-
Rhea-AI Summary

HealthLynked Corp. (OTCQB: HLYK) has appointed Jeremy Daniel as its new Chief Financial Officer (CFO), effective immediately. Daniel brings over two decades of experience in financial management, strategic planning, and organizational development. His most recent position was CFO at Innoveren Scientific, where he raised over $100M in funding through public and private equity markets and led successful acquisitions.

Daniel's previous roles include CFO at Regenerative Medicine Solutions and controller at Omnicare. He is a Certified Public Accountant (CPA) with an MBA from Xavier University. In his new role, he will oversee HealthLynked's financial strategy and operations, focusing on driving growth, operational efficiency, and shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

HealthLynked Corp. (OTCQB: HLYK) has received a $500,000 payment milestone from the sale of ACO Health Partners (AHP), representing their share of AHP's ACO shared savings for the 2023 performance period. This payment completes the total cash consideration of $3 million from the January 2023 sale, which included an initial $750,000 payment, $1.75 million in participation-based payments, and the current $500,000 milestone. The sale to Palm Beach ACO was a strategic move allowing HealthLynked to focus on its core healthcare technology and patient engagement services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.53%
Tags
none
-
Rhea-AI Summary

HealthLynked Corp. (OTCQB: HLYK) announced Q3 2024 financial results, revealing significant changes amid strategic restructuring. Revenue declined 56% year-over-year to $0.59 million in Q3 2024, with a nine-month revenue of $2.39 million, down 50% from 2023. The company reduced practice operating expenses by 39% to $0.80 million in Q3. Operating loss increased to $1.67 million, with a net loss of $1.97 million. The company is shifting focus from clinical operations to app-based services, with telemedicine now available nationwide. CEO Dr. Michael Dent provided $2.7 million in debt funding in 2024 to support the transition.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.33%
Tags
none
-
Rhea-AI Summary

HealthLynked Corp has announced a significant update to its Oohvie app, integrating telemedicine services and online scheduling capabilities. The enhanced platform now offers women comprehensive healthcare management through a single mobile application. The update features a redesigned home screen, improved user interface, and expanded functionalities including virtual consultations with healthcare providers. The app follows a freemium model, with basic tracking features available for free and premium services, including telemedicine access, available through a subscription at $12 monthly or $120 annually.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.05%
Tags
none
Rhea-AI Summary

HealthLynked Corp. (OTCQB: HLYK) has announced a strategic partnership with 3X4 Genetics to enhance its member offerings. This collaboration aims to provide personalized genetic insights and improved healthcare services to HealthLynked members. The partnership allows members to purchase the 3X4 Blueprint for genetic testing at $299 through HealthLynked's website.

HealthLynked CEO, Michael Dent, M.D., emphasized that this partnership demonstrates their commitment to delivering cutting-edge healthcare solutions and personalized care. 3X4 Genetics CEO, Tony Hsu, highlighted the alignment between both companies in empowering patients with genetic information for optimized health and wellness.

This collaboration is part of HealthLynked's broader strategy to expand its network of strategic alliances, focusing on improving patient health through advanced diagnostics and wellness programs. The company plans to forge similar partnerships in the coming months to increase the range of services available to its members.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.02%
Tags
partnership
-
Rhea-AI Summary

HealthLynked Corp. (OTCQB: HLYK) has filed a non-provisional patent with the USPTO for ARi, an AI-powered personal healthcare assistant. ARi utilizes GPT and LLM technologies to provide personalized medical recommendations based on users' comprehensive health profiles. This innovative tool aims to address the challenge of inaccurate self-diagnosis from internet searches by incorporating patients' medical records for more tailored guidance.

Dr. Michael Dent, CEO of HealthLynked, emphasized that while ARi represents a significant advancement in patient engagement and personalized care, it is designed to supplement, not replace, professional medical consultations. The potential impact of AI in healthcare is substantial, with estimates suggesting it could save the U.S. healthcare system up to $150 billion annually by 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
AI
-
Rhea-AI Summary

HealthLynked Corp. (OTCQB: HLYK) has partnered with Lyric Health to launch Virtual Urgent Care, offering 24/7 telehealth services in all 50 states. Patients can connect with licensed physicians within 20 minutes for non-emergency medical concerns. The company plans to expand with Virtual Primary Care, allowing scheduled appointments with primary care physicians.

HealthLynked's comprehensive virtual care suite includes primary care, urgent care, mental health, dermatology, specialty referrals, and pet care. The service is accessible through the HealthLynked app, with visits priced at $70 or $50 for subscribers ($12/month or $120/year). This partnership aims to provide affordable and accessible healthcare nationwide, integrating with HealthLynked's existing medical record storage and prescription voucher program.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.57%
Tags
partnership
Rhea-AI Summary

HealthLynked Corp. (OTCQB: HLYK) reported its Q2 and H1 2024 financial results, highlighting a strategic shift towards app-based technology services. Key points include:

- Q2 2024 revenue of $0.78 million, down 21% from Q1 2024 and 53% from Q2 2023
- H1 2024 revenue of $1.80 million, down 48% from H1 2023
- 42% reduction in Health Services Division operating expenses in Q2 2024
- 8% improvement in loss from operations in Q2 2024 compared to Q1 2024
- Expansion of telemedicine services nationwide
- Partnership with RxSpark for prescription drug discounts

The company is focusing on cost reduction and transitioning from clinical operations to app-based services, aiming to expand its membership base and enhance healthcare delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags

FAQ

What is the current stock price of Healthlynked (HLYK)?

The current stock price of Healthlynked (HLYK) is $0.05356 as of February 25, 2025.

What is the market cap of Healthlynked (HLYK)?

The market cap of Healthlynked (HLYK) is approximately 13.0M.

What does HealthLynked Corp do?

HealthLynked Corp integrates patients with healthcare providers through a technology platform, offering solutions like real-time scheduling, electronic medical records, online telemedicine, and more.

What recent achievements has HealthLynked Corp made?

HealthLynked recently launched advanced search functionalities on its website and mobile applications to improve healthcare accessibility and connectivity.

How does HealthLynked benefit patients?

HealthLynked offers features such as real-time scheduling, electronic medical records, and online telemedicine, which help reduce wait times and improve the accuracy and portability of medical information.

How does HealthLynked benefit healthcare providers?

Providers in the HealthLynked network benefit from improved patient care, operational insights, and marketing tools to engage with patients, ensuring better compliance and optimized scheduling.

Who leads HealthLynked Corp?

HealthLynked Corp is led by CEO Dr. Michael Dent and CTO Chris Hall.

What is the HealthLynked Network?

The HealthLynked Network is a cloud-based platform that allows members to manage their healthcare by providing a secure, centralized location for their medical data.

How can I stay updated with HealthLynked Corp's news?

You can stay updated with HealthLynked Corp's news by visiting their website and following their social media channels on Facebook, Twitter, Instagram, and LinkedIn.

What initiatives does HealthLynked take to enhance healthcare?

HealthLynked creates new strategies and initiatives that connect patients with their family members and doctors, encouraging active participation in their healthcare.

How do I join the HealthLynked Network as a healthcare provider?

Healthcare providers can join the HealthLynked Network by claiming their profiles and completing the necessary steps to become an in-network provider.

Is HealthLynked publicly traded?

Yes, HealthLynked Corp is publicly traded on the OTCQB under the symbol HLYK.
Healthlynked

OTC:HLYK

HLYK Rankings

HLYK Stock Data

13.00M
187.63M
33.45%
0.03%
Medical Care Facilities
Healthcare
Link
United States
Naples